| Literature DB >> 34432484 |
Triana Amen1, Anthony Guihur2, Christina Zelent3, Robertas Ursache2, Jörg Wilting3, Daniel Kaganovich1,4.
Abstract
Stress granules (SGs) are ribonucleoprotein functional condensates that form under stress conditions in all eukaryotic cells. Although their stress-survival function is far from clear, SGs have been implicated in the regulation of many vital cellular pathways. Consequently, SG dysfunction is thought to be a mechanistic point of origin for many neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS). Additionally, SGs are thought to play a role in pathogenic pathways as diverse as viral infection and chemotherapy resistance. There is a growing consensus on the hypothesis that understanding the mechanistic regulation of SG physical properties is essential to understanding their function. Although the internal dynamics and condensation mechanisms of SGs have been broadly investigated, there have been fewer investigations into the timing of SG formation and clearance in live cells. Because the lifetime of SG persistence can be a key factor in their function and tendency toward pathological dysregulation, SG clearance mechanisms deserve particular attention. Here we show that resveratrol and its analogues piceatannol, pterostilbene, and 3,4,5,4'-tetramethoxystilbene induce G3BP-dependent SG formation with atypically rapid clearance kinetics. Resveratrol binds to G3BP, thereby reducing its protein-protein association valency. We suggest that altering G3BP valency is a pathway for the formation of uniquely transient SGs.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34432484 PMCID: PMC8693967 DOI: 10.1091/mbc.E21-02-0066
Source DB: PubMed Journal: Mol Biol Cell ISSN: 1059-1524 Impact factor: 4.138
FIGURE 1:Resveratrol, piceatannol, pterostilbene, and 3,4,5,4′-tetramethoxystilbene induce SG formation. (A) Chemical structure of resveratrol (CID 445154), piceatannol (CID 667639), pterostilbene (CID 5281727), and 3,4,5,4′-tetramethoxystilbene (CID 5388065). (B) Immunofluorescence of SG markers in PABPC1-DDR2 HEK293T cells treated with resveratrol (100 μM), piceatannol (100 μM), pterostilbene (100 μM), 3,4,5,4′-tetramethoxystilbene (100 μM), and arsenite (100 μM) for 1 h. Cells were fixed and stained with anti-TIA1 and anti-G3BP antibodies. Hoechst (10 μg/ml) was used to stain the nucleus 15 min before the imaging. Confocal planes are shown; scale bar 5 μm. (C, D) Confocal microscopy and quantification of SG formation in HEK293T cells expressing endogenously tagged PABPC1-DDR2 during treatment with resveratrol (200 μM), piceatannol (100 μM), pterostilbene (100 μM), 3,4,5,4′-tetramethoxystilbene (100 μM), and arsenite (100 μM) for 1 h, with and without cycloheximide (10 μg/ml, simultaneous addition); scale bar 5 μm. Quantification shows the ratio of cells with SGs in the population, mean ± SEM, n = 3 ratios pooled from 300 cells. (E) Western blot of eIF2α phosphorylation on Ser51 in HeLa cell lysates. Cells were treated with resveratrol (Resv, 200 μM), piceatannol (Picea, 100 μM), pterostilbene (Ptero, 100 μM), 3,4,5,4′-tetramethoxystilbene (Tms, 100 μM), and arsenite (Ars, 100μ M) for 1 h before lysis. * p < 0.01.
FIGURE 2:Resveratrol- and piceatannol-induced SGs are smaller with similar formation kinetics. (A) Confocal microscopy of SG fusion in HEK293T cells expressing endogenously tagged PABPC1-DDR2 treated with resveratrol (100 μM) and arsenite (100 μM) for 30 min; scale bar 5 μm. (B) Transmission electron microscopy of SGs in SHSY-5Y cells prestained with anti-G3BP gold antibodies. N indicates nuclei; arrowheads indicate SGs; scale bar 500 nm. (C) Quantification of the SG size in the population, box and whisker plot, mean ± SEM, n = 100. * p < 0.05. Confocal microscopy images were used for the quantification. (D, E) Quantification and confocal microscopy of SG formation in HEK293T cells expressing endogenously tagged PABPC1-DDR2 treated with arsenite (200 μM), piceatannol (200 μM), or resveratrol (200 μM) for indicated amounts of time. D, Line graph shows average SG size change over time, mean ± SEM, n = 30 for each time point and treatment. E, Representative confocal images are shown; scale bar 5 μm. (F) Schematic of photoconversion (PhoC) using PABPC1-DDR2. Confocal planes show single SGs in live HEK293T cells expressing CRISPR/Cas9 tagged PABPC1-DDR2 during and after photoconversion. (G, H) Fluorescence intensity profiles of a single SG during photoconversion and diffusion under resveratrol, B, and arsenite conditions, C. Red graphs represent photoconverted DDR2 population. (I) Quantification of the photoconverted PABPC1-DDR2 diffusion time inside single SGs under resveratrol and arsenite conditions; mean ± SEM; n = 15; nonsignificant differences.
FIGURE 3:Resveratrol induces SGs in A. thaliana seedlings. (A) Confocal microscopy of yeast, S. cerevisiae expressing endogenously tagged Pab1-GFP SG marker grown to the mid-log phaser and treated with the indicated concentrations of resveratrol, or starved for 1 h; representative images are shown, Quantification shows the proportion of cells with SGs in the population; mean ± SEM; n = 3 pooled from 300 cells. * p < 0.01. (B) Confocal microscopy of A. thaliana root cells expressing GFP-tagged Rbp47b SG marker incubated in the control, heat stress (41°C for 40 min in darkness), or resveratrol (200 μM for 45 min). Representative images are shown; scale bar 10 μm. Cell walls are visualized by propidium iodide staining. (C) Confocal microscopy of A. thaliana root cells expressing GFP-tagged Rbp47b SG marker incubated in resveratrol or under heat stress with or without cycloheximide (CHX) for 45 min (CHX 200 ng μl−1 was added together with resveratrol). Cell walls are visualized by propidium iodide dye. Representative images are shown; scale bar 10 μm. (D) Quantification shows the ratio of cells with SGs in the population; mean ± SEM; n = 3 pooled from 300 cells. * p < 0.01.
FIGURE 4:G3BP is required for the formation of resveratrol-induced SGs. (A) Confocal microscopy of SG formation in U2OS WT and G3BP1/2 KO cells during treatment with resveratrol (400 μM) and arsenite (400 μM) for 1 h; scale bar 5 μm. (B, C) Confocal microscopy of SG formation in U2OS G3BP1/2 KO cells overexpressing RFP-G3BP1 or RFP-G3BP F33A during treatment with resveratrol (400 μM) and arsenite (400 μM) for 1 h; scale bar 5 μm. (D) Quantification shows the proportion of cells with SGs in the population; mean ± SEM; n = 3 ratios pooled from 300 cells for each condition. (E) Model of hypothetical SG formation with a reduced valence of its core nucleating factor.
FIGURE 5:Resveratrol- and piceatannol-induced SGs clear immediately upon stress removal. (A, B) Confocal microscopy and quantification of SG formation in HEK293T cells expressing USP10(1-40)-mCherry WT and F10A fragment and CRISPR/Cas9 tagged PABPC1-DDR2 treated with resveratrol (100 μM) or arsenite (100 μM) for 1 h; scale bar 5 μm. Quantification shows the proportion of cells with SGs in the population of cells expressing the constructs; mean ± SEM; n = 3 pooled from 300 cells. * p < 0.01. (C, D) Quantification and confocal microscopy of SG clearance in HEK293T cells expressing endogenously tagged PABPC1-DDR2 treated with arsenite (200 μM), piceatannol (200 μM), or resveratrol (200 μM) for 1 h, washed three times with PBS, and imaged for 1 h. (E) Model of SG formation and clearance under arsenite and resveratrol conditions. Line graph shows average SG size change over time; mean ± SEM, pooled from at least 100 cells for each time point and treatment. (F) Representative confocal images are shown. Scale bar 5 μm.
Plasmids used in this study.
| Plasmid name | Source |
|---|---|
| pcDNA3.1-USP10(40aa)-mCherry | This study |
| pcDNA3.1-USP10(40aa)-F10A-mCherry | This study |
| pRFP-G3BP | Kaganovich laboratory |
| pRFP-G3BP F33A | This study |